WCN26-7629 SUCCESSFUL TREATMENT WITH TELITACICEPT,GLUCOCORTICOIDS AND IMMUNOSUPPRESSANTS IN A REFRACTORY IGA NEPHROPATHY PATIENT WITH STAGE CKD4: A CASE REPORT

Read full text Summarise with VIRAT
Authors: Dingwei Yang, Sha Chen, Miao Feng
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Immunoglobulin A nephropathy (IgAN), the most common primary glomerular disease worldwide, is a leading cause of end-stage renal disease. However, effective treatment options remain limited for refractory IgAN patients with stage CKD 4.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes Vasculitis and related conditions

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104390–104390
Publication date
25 March 2026
Language
EN